Pharming Group N.V. vs Bausch Health Companies Inc.: Examining Key Revenue Metrics

Pharmaceutical Giants: Revenue Trends from 2014 to 2023

__timestampBausch Health Companies Inc.Pharming Group N.V.
Wednesday, January 1, 2014826350000025762439
Thursday, January 1, 20151049880000011838278
Friday, January 1, 2016967400000016693660
Sunday, January 1, 20178724000000107517335
Monday, January 1, 20188380000000154575611
Tuesday, January 1, 20198601000000189333721
Wednesday, January 1, 20208027000000228394666
Friday, January 1, 20218434000000189853037
Saturday, January 1, 20228124000000205622000
Sunday, January 1, 20238757000000245316000
Loading chart...

Igniting the spark of knowledge

A Tale of Two Companies: Pharming Group N.V. and Bausch Health Companies Inc.

In the ever-evolving pharmaceutical industry, revenue growth is a key indicator of a company's success. From 2014 to 2023, Bausch Health Companies Inc. consistently outperformed Pharming Group N.V. in terms of revenue. Bausch Health's revenue peaked in 2015, reaching approximately $10.5 billion, while Pharming Group's highest revenue was around $245 million in 2023. Despite Bausch Health's revenue being nearly 40 times greater than Pharming Group's, the latter showed a remarkable growth trajectory, increasing its revenue by over 850% from 2014 to 2023. This stark contrast highlights the diverse strategies and market positions of these two companies. As the pharmaceutical landscape continues to shift, these revenue trends offer valuable insights into the competitive dynamics and potential future directions of these industry players.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025